964. Real-world dalbavancin use for serious gram-positive bacterial infections: comparing outcomes between people who use and do not use drugs

BACKGROUND: Dalbavancin has been used off label to treat invasive gram-positive bacterial infections due to its long half-life, eliminating the need for long term IV access and prolonged hospital stays. It is a particularly useful option in vulnerable populations such as people who use drugs (PWUD)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zambrano, Sarah, Paras, Molly L, Suzuki, Joji, Pearson, Jeffrey C, Schrager, Harry, Mallada, Jason, Dionne, Brandon, Fairbank-Haynes, Katie, Kalter, Marlene, Szpak, Veronica, Prostko, Sara, Solomon, Daniel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678280/
http://dx.doi.org/10.1093/ofid/ofad500.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678280/
http://dx.doi.org/10.1093/ofid/ofad500.025

Ejemplares similares